Natural Killer/T-Cell Lymphoma Invading the Orbit and Globe

References

• Choi KH, Lee SJ, Suh YL, Kim YD. Nasal-type natural killer/T-cell lymphoma of the orbit. J Korean Ophthalmol Soc 2004;45:2145–2150.
   Google Scholar
• Cimino L, Chan C-C, Shen D, Masini L, Ilariucci F, Masetti M, Asioli S, Sartori A, Cappuccini L. Ocular involvement in nasal natural killer T-cell lymphoma. Int Ophthalmol 2009;29 (4):275–279.
   PubMedGoogle Scholar
• Aozasa K, Zaki MA. Epidemiology and pathogenesis of nasal NK/T-cell lymphoma: a mini-review. Sci World J 2011;11:422–428.
   Google Scholar
• Coupland SE, Foss HD, Assaf C, Auw-Haedrich C, Anastassiou G, Anagnostopoulos I, Hummel M, Karesh JW, Lee WR, Stein H. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 1999;106 (11):2109–2120.
   PubMed Web of Science ®Google Scholar
• Hon C, Kwok AK, Shek TW, Chim JC, Au WY. Vision-threatening complications of nasal T/NK lymphoma. Am J Ophthalmol 2002;134 (3):406–410.
   PubMed Web of Science ®Google Scholar
• Mo ZY, Wang P, Yang HW, Li WB, Liang QL. Esophageal metastasis secondary to extranodal nasal-type natural killer/T-cell lymphoma: a case report. Mol Clin Oncol 2016;5 (1):207–209.
   Web of Science ®Google Scholar
• Sandner A, Helmbold P, Winkler M, Gattenlöhner S, Müller-Hermelink H-K, Holzhausen HJ. Cutaneous dissemination of nasal NK/T-cell lymphoma in a young girl. Clin Exp Dermatol 2008;33 (5):615–618.
   Web of Science ®Google Scholar
• Romero-Guadarrama MB, Aguilar-Martínez E. Extranodal nasal NK/ T-cell lymphoma with dissemination to the central nervous system: a case report. Acta Cytol 2010;54 (5 Suppl):993–997.
   Web of Science ®Google Scholar
• Kim JW, An JH. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis. J Craniofac Surg 2014;25 (2):509–511.
   Web of Science ®Google Scholar
• Ely A, Evans J, Sundstrom JM, Malysz J, Specht CS, Wilkinson M. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature. Orbit 2012;31 (4):267–269.
   PubMedGoogle Scholar
• Abe RY, Pinto RDP, Bonfitto JFL, Lira RPC, Arieta CEL. Ocular masquerade syndrome associated with extranodal nasal natural killer/T-cell lymphoma: case report. Arq Bras Oftalmol 2012;75 (6):430–432.
   Web of Science ®Google Scholar
• Cheung MM, Chan JK, Lau WH, Foo W, Chan PT, Ng CS, Ngan RK. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16 (1):70–77.
   PubMed Web of Science ®Google Scholar
• Au WY. Current management of nasal NK/T-cell lymphoma. Oncology (Williston Park) 2010;24 (4):352–328.
   Web of Science ®Google Scholar
• Tse E, Kwong YL. Diagnosis and management of extranodal NK/T cell lymphoma nasal type. Expert Rev Hematol 2016;9 (9):861–871.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Kita K, Miwa H, Mishii K, Oka K, Ohno T, Shirakawa S, Fukumoto M. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 1995;76 (11):2351–2356.
   PubMed Web of Science ®Google Scholar
• Tse E, Kwong YL. Management of advanced NK/T-cell lymphoma. Curr Hematol Malig Rep 2014;9 (3):233–242.
   Web of Science ®Google Scholar
• Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011;29 (33):4410–4416.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, Xia YF, Xia ZJ. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/ IIE extranodal natural killer/T-cell lymphoma. Cancer 2013;119 (2):348–355.
   PubMed Web of Science ®Google Scholar